Category: Uncategorized
-
Dupixent Lawsuits Being Filed for Patients: Medical Information and Legal Allegations
These Dupixent Cases Involving T-cell Lymphoma Cancer Are Against Regeneron Pharmaceuticals and Sanofi-Aventis (Posted by Tom Lamb at Drug Injury Watch) We are currently investigating possible Dupixent lawsuits for patients who were diagnosed with a relatively rare…
-
Meningioma Warning For Depo-Provera Recommended in Europe by Drug Regulator
Why Has This September 2024 European Medicines Agency (EMA) Action Not Been Followed by FDA in US? (Posted by Tom Lamb at Drug Injury Watch) One of the primary issues in the increasing number of Depo-Provera meningioma…
-
Off-Topic News: Camp Lejeune Lawsuits for Cancers due to Contaminated Water During 1953-1987 Now Allowed
People Need to File a Federal Court Lawsuit in the Eastern District of North Carolina Before August 8, 2024 Filing Deadline (Posted by Tom Lamb at Drug Injury Watch) Veterans who served at Camp Lejeune…
-
Beovu Safety Signal Found By External Review Committee Which Evaluated Beovu Post-Marketing Adverse Events
New Vision-Related Side Effects Warnings For Beovu Eye Injections Have Been Added In US, Australia, And Switzerland, Thus Far (Posted by Tom Lamb at DrugInjuryWatch.com) In this recent article, “Beovu Label Change:…
-
Belviq Lawsuits: Cancers Associated With Belviq Diet Drug Recall Include Pancreatic, Colorectal, Lung
Patients On Belviq Developing Cancer File Lawsuits Against Responsible Drug Company For Failure To Warn (Posted by Tom Lamb at DrugInjuryWatch.com) The Belviq recall was announced in February 2020 after the FDA…
-
Belviq Cancer Risk Warning Alert Issued To Patients And Doctors In January 2020 FDA Drug Safety Communication
Recent Clinical Trial Findings Suggest Use Of The Weight-Loss Medicine Belviq Increased Risk Of Cancers (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: "FDA requests the withdrawal of the weight-loss drug Belviq, Belviq…
-
Patients Treated With Imbruvica Had Increased Rate Of Fatal Cardiac Events Compared To Conventional Chemotherapy
Cardiovascular Adverse Drug Reactions Often Occurred Soon After Administration Of Imbruvica, According To Recent Medical Study (Posted by Tom Lamb at DrugInjuryWatch.com) Patients treated with Imbruvica (ibrutinib) had an increased occurrence of…
-
Lymphoma Cancer Associated With Breast Implants: FDA Advisory Committee Meeting March 2019
Warning Letters Sent To Companies Mentor Worldwide And Sientra For Breast Implants Safety Monitoring Failures (Posted by Tom Lamb at DrugInjuryWatch.com) Albeit a bit off-topic for the general focus of this Drug…
-
Breast Implants Lymphoma Cancer Cases Updates For United States And Canada: February 2019
Additional Cases Of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Reported To FDA, Health Canada (Posted by Tom Lamb at DrugInjuryWatch.com) For our first 2019 update about breast implant-associated anaplastic large cell…